STOCKHOLDERS' DEFICIT |
3 Months Ended |
|---|---|
Jun. 30, 2025 | |
| STOCKHOLDERS' DEFICIT | |
| STOCKHOLDERS' DEFICIT | NOTE 4 - STOCKHOLDERS’ DEFICIT
Common Stock
The Company is authorized to issue 3,000,000,000 shares of common stock.
On November 16, 2021, the board of directors approved a 5-in-1 reverse stock split for the Company’s common stock. On July 27, 2022, the Financial Industry Regulatory Authority (“FINRA”) also approved the 5-in-1 reverse stock split. The reverse stock split was retrospectively reflected throughout the consolidated financial statements and footnotes.
On February 14, 2023, the Company entered into Subscription Agreements for Placement of Shares with the six targeted subscribers. The Company raised proceeds of US$120,000 with par value of US$0.001 per share, and issue 120,000,000 shares to the targeted subscribers. These common shares became effective from February 22, 2023.
As of June 30, 2025 and March 31, 2025, the Company has 121,983,993 shares of common stock issued and outstanding. |